Clinical Trial Update: Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating enoxaparin versus placebo for preventing venous thromboembolism in low-risk cancer patients after surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Venous Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University of Utah | Conditions: Venous Thromboembolism, Bleeding as Surgical Complication (Treatment) | Phase 4 | Status: WITHDRAWN